4//SEC Filing
Cheruvu Pavan 4
Accession 0001209191-19-025189
CIK 0001636050other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 9:14 PM ET
Size
8.8 KB
Accession
0001209191-19-025189
Insider Transaction Report
Form 4
Cheruvu Pavan
Chief Executive Officer
Transactions
- Award
Stock Option ( Right to Buy)
2019-04-15+1,596,000→ 1,596,000 totalExercise: $1.06Exp: 2029-04-14→ Common Stock (1,596,000 underlying) - Award
Stock Option ( Right to Buy)
2019-04-15+1,596,000→ 1,596,000 totalExercise: $1.06Exp: 2029-04-14→ Common Stock (1,596,000 underlying)
Footnotes (3)
- [F1]The option vests over a period of four years, with one quarter of the common shares underlying the option vesting on April 15, 2020 and the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date.
- [F2]The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- [F3]One-third of the option will vest at such time as the Issuer's 30-day trailing volume weighted average closing stock price ("30-day VWAP") is equal to $2.12; one-third of the option will vest at such time as the Issuer's 30-day VWAP stock price is equal to $4.24; and one-third of the option will vest at such time as the Issuer's 30-day VWAP stock price is equal to $6.36, in each case subject to the Reporting Person providing continuous service to the Issuer on each such date.
Documents
Issuer
Axovant Sciences Ltd.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001731741
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 9:14 PM ET
- Size
- 8.8 KB